Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Starting financial planning for retirement is crucial for a secure future. Learn the best time to begin and set your goals effectively.
20,958 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Barclays just boosted its Oracle price target to $240, highlighting a sharper focus on Oracle's cloud expansion and A...
Oil prices edge higher around $99 a barrel on March 12, 2026, as markets assess supply constraints and demand trends....
Stocks edge higher pre-market as oil nears $100 a barrel, lifting energy names while weighing inflation and growth pr...
Billionaire investor Bill Ackman continues to chase value in everyday choices, even as his net worth sits among the u...
Institutional buyers returned to digital assets in force, with BlackRock at the helm, buying roughly $600 million in ...
A leading layer-1 in the crypto world, Solana is making waves with a notable price move. This article breaks down why...
XRP has fallen from recent highs, but a rebound back above $2 is on the table if key catalysts align. This guide brea...
As tensions flare, on-chain futures venue Hyperliquid and its HYPE token surge into crypto's top tier. Traders turn t...
The 2025 ATTOM report shows a sharp slowdown in home flipping activity, with profits slipping to pre-crisis levels as...
The Trade Desk just fell to a multi-year low, sparking a debate between momentum fans and value hunters. This guide b...
AI optimism pushed valuations to lofty highs. This guide explains why stocks wall street says to be cautious about tw...